PTIX Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. (PTIX) Institutional Ownership
What the institutions did with PTIX last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Only 4 managers reported a position this quarter, so the percentages above describe a very small sample.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| DRW Securities, LLC | 41.8K | 62.6% |
| FNY Investment Advisers, LLC | 25.0K | 37.4% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| CoreCap Advisors, LLC | Sold Out | 100 | 0 | -100 |
| United Financial Planning Group LLC | Sold Out | 17 | 0 | -17 |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.